Cargando…
Adalimumab for treatment of very early onset inflammatory bowel disease
Autores principales: | Xie, Yao, Liu, Li-Li, Jiang, Yi, Tang, Ze-Zhong, Sun, Guo-Yu, Hou, Xin-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940072/ https://www.ncbi.nlm.nih.gov/pubmed/31856064 http://dx.doi.org/10.1097/CM9.0000000000000528 |
Ejemplares similares
-
Recent Advance in Very Early Onset Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2019) -
Recent advance in very early-onset inflammatory bowel disease
por: Shim, Jung Ok
Publicado: (2019) -
Efficacy of infliximab and adalimumab therapy in very early onset, severe ulcerative colitis
por: Rohani, Pejman, et al.
Publicado: (2021) -
The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease
por: Zheng, Hengqi B., et al.
Publicado: (2021) -
Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease
por: Shaul, Eliana, et al.
Publicado: (2022)